INLETRYN Trademark

Trademark Overview


On Tuesday, November 20, 2012, a trademark application was filed for INLETRYN with the United States Patent and Trademark Office. The USPTO has given the INLETRYN trademark a serial number of 85783809. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 25, 2016. This trademark is owned by Eli Lilly and Company. The INLETRYN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
inletryn

General Information


Serial Number85783809
Word MarkINLETRYN
Filing DateTuesday, November 20, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antidepressants
Translation of Words in MarkThe wording "INLETRYN" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 29, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 25, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 25, 2016ABANDONMENT - NO USE STATEMENT FILED
Friday, October 2, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 1, 2015EXTENSION 5 GRANTED
Tuesday, September 29, 2015EXTENSION 5 FILED
Tuesday, September 29, 2015TEAS EXTENSION RECEIVED
Friday, May 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 28, 2015EXTENSION 4 GRANTED
Friday, May 15, 2015EXTENSION 4 FILED
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Friday, November 14, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 13, 2014EXTENSION 3 GRANTED
Friday, November 7, 2014EXTENSION 3 FILED
Friday, November 7, 2014TEAS EXTENSION RECEIVED
Saturday, May 24, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 23, 2014EXTENSION 2 GRANTED
Tuesday, May 20, 2014EXTENSION 2 FILED
Tuesday, May 20, 2014TEAS EXTENSION RECEIVED
Friday, January 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2014EXTENSION 1 GRANTED
Tuesday, November 19, 2013EXTENSION 1 FILED
Saturday, January 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 19, 2013TEAS EXTENSION RECEIVED
Tuesday, June 18, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 23, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 23, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 3, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 14, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 12, 2013ASSIGNED TO EXAMINER
Thursday, November 29, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, November 23, 2012NEW APPLICATION ENTERED IN TRAM